机构:[1]Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases, the Ministry of Education Key Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[2]Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[3]State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[4]Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100021 Beijing, China.[5]National Infrastructure for Translational Medicine, Institute of Clinical Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[6]Department of Orthopedics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[7]Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[8]Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, 100730 Beijing, China.[9]Department of Thoracic Oncology, Cancer Center, and Laboratory of Clinical Cell Therapy, West China Hospital, Sichuan University, 610041 Chengdu, China.四川大学华西医院[10]Department of Rheumatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Clinical Immunology Center, Chinese Academy of Medical Sciences, 100730 Beijing, China.
National Key R&D Program
of China (2022YFC3602000, X.Z.), the Chinese Academy of Medical
Science Innovation Fund for Medical Sciences (CIFMS) (2023-I2M-C&TB-041, H.Y., 2021-I2M-1-016, H.Y., 2021-I2M-1-017, X.Z., 2020-I2M-C&T-B011, H.Y., 2021-I2M-1-047, M.W.), National High-Level Hospital Clinical
Research Funding (2022-PUMCH-A-106, H.Y., BJ-2022-116, X.Z., BJ-2023-
084, M.W.), Chinese Society of Clinical Oncology (CSCO)‐Pilot Oncology Research Fund (Y-2019AZMS-0452, H.Y.), National Natural Science
Foundation of China (82230060, X.Z., 81788101, X.Z., 32141004 X.Z,
82203021 X.Z., 82171799, X.J.), and Peking Union Medical College Hospital Research funding for Postdoc (kyfyjj202317, Z.Z.).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
无
最新[2023]版:
大类|1 区综合性期刊
小类|1 区综合性期刊
第一作者:
第一作者机构:[1]Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases, the Ministry of Education Key Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[2]Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[3]State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Rheumatology and Clinical Immunology, National Clinical Research Center for Dermatologic and Immunologic Diseases, the Ministry of Education Key Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[2]Clinical Immunology Center, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.[3]State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 100730 Beijing, China.
推荐引用方式(GB/T 7714):
Ziyue Zhou,Xiaoxiang Zhou,Xu Jiang,et al.Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis[J].Nature Communications.2024,15(1):2107.doi:10.1038/s41467-024-46195-x.
APA:
Ziyue Zhou,Xiaoxiang Zhou,Xu Jiang,Bo Yang,Xin Lu...&Xuan Zhang.(2024).Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis.Nature Communications,15,(1)
MLA:
Ziyue Zhou,et al."Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis".Nature Communications 15..1(2024):2107